ON24 CEO Sharan Sharat exercises options and sells shares under 10b5-1 plan
Rhea-AI Filing Summary
Insider transactions by ON24, Inc. (ONTF): The reporting person, Sharan Sharat (President, CEO, Director and >10% owner), executed transactions on 09/16/2025 under a Rule 10b5-1 plan adopted May 14, 2025. Mr. Sharat exercised stock options with an exercise price of $0.89 to acquire 53,459 shares, increasing option-based common shares underlying to 106,918. He also sold 32,159 shares in multiple trades at a weighted average price of $5.5506 per share, with sale prices ranging between $5.46 and $5.62. Following these transactions, he beneficially owned 3,620,863 shares.
Positive
- Exercise of options: Reporting person exercised 53,459 options at an exercise price of $0.89.
- Use of Rule 10b5-1 plan: The sale was effected pursuant to a documented 10b5-1 trading plan adopted May 14, 2025.
Negative
- Insider sale: 32,159 shares were sold at a weighted average price of $5.5506, reducing direct holdings.
- High beneficial ownership concentration: After transactions, the reporting person still beneficially owned 3,620,863 shares, indicating significant insider exposure.
Insights
TL;DR: Insider exercised options and sold a portion of shares under a pre-established trading plan, netting liquidity.
The Form 4 shows a contemporaneous option exercise and partial sale executed under a Rule 10b5-1 plan. The exercise converted in-the-money options priced at $0.89 into 53,459 shares while a subsequent disposition of 32,159 shares occurred at a weighted average of $5.5506. These are routine Section 16 disclosures for an executive who is also a significant shareholder; the filing documents the mechanics and resulting beneficial ownership of 3,620,863 shares.
TL;DR: Significant insider sale by a top executive occurred under a preplanned trading arrangement; governance watchers will note timing and ownership level.
The report confirms the director and CEO uses a documented 10b5-1 plan adopted May 14, 2025, for the sales on 09/16/2025. The combination of option exercise and sale is disclosed, including price ranges and post-transaction beneficial ownership. While procedural safeguards are present (10b5-1 plan), stakeholders often review such filings for cadence and frequency of sales relative to insider ownership concentration and corporate milestones.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 53,459 | $0.00 | -- |
| Exercise | Common Stock | 53,459 | $0.89 | $48K |
| Sale | Common Stock | 32,159 | $5.5506 | $179K |
Footnotes (1)
- The transaction reported in this Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on May 14, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $5.46 to $5.62 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in footnote (2) to this Form 4. The options are fully vested and exercisable.
